Works by Yasuhiko Munakata

Results: 7
    1

    Somatic mutation in autoantibody-associated V.

    Published in:
    European Journal of Immunology, 1998, v. 28, n. 5, p. 1435, doi. 10.1002/(SICI)1521-4141(199805)28:05<1435::AID-IMMU1435>3.0.CO;2-R
    By:
    • Munakata, Yasuhiko;
    • Saito, Shin-ichiro;
    • Hoshino, Atsushi;
    • Muryoi, Tai;
    • Hirabayashi, Yasuhiko;
    • Shibata, Shinobu;
    • Miura, Toshihiko;
    • Ishii, Tomonori;
    • Funato, Tadao;
    • Sasaki, Takeshi
    Publication type:
    Article
    2
    3

    Successful Application of Tocilizumab in a Patient With Neoadjuvant Immunochemotherapy‐Induced Cytokine Release Syndrome.

    Published in:
    Cancer Reports, 2024, v. 7, n. 7, p. 1, doi. 10.1002/cnr2.2145
    By:
    • Minami, Soichiro;
    • Kawashima, Yosuke;
    • Munakata, Yasuhiko;
    • Matsuno, Masahiro;
    • Hara, Shuichiro;
    • Yamazaki, Yusuke;
    • Doman, Tsuyoshi;
    • Saito, Shin;
    • Odaka, Tetsuo;
    • Ogasawara, Takahiro;
    • Shimizu, Hisashi;
    • Sugisaka, Jun;
    • Aiba, Tomoiki;
    • Toi, Yukihiro;
    • Yamanda, Shinsuke;
    • Kimura, Yuichiro;
    • Sugawara, Shunichi
    Publication type:
    Article
    4

    Feasibility of methotrexate discontinuation following tocilizumab and methotrexate combination therapy in patients with long-standing and advanced rheumatoid arthritis : a 3-year observational cohort study.

    Published in:
    Fukushima Journal of Medical Science, 2023, v. 69, n. 1, p. 11, doi. 10.5387/fms.2022-06
    By:
    • Masayuki Miyata;
    • Yasuhiko Hirabayashi;
    • Yasuhiko Munakata;
    • Yukitomo Urata;
    • Koichi Saito;
    • Hiroshi Okuno;
    • Masaaki Yoshida;
    • Takao Kodera;
    • Ryu Watanabe;
    • Seiya Miyamoto;
    • Tomonori Ishii;
    • Shigeshi Nakazawa;
    • Hiromitsu Takemori;
    • Takanobu Ando;
    • Takashi Kanno;
    • Masataka Komagamine;
    • Ichiro Kato;
    • Yuichi Takahashi;
    • Atsushi Komatsuda;
    • Kojiro Endo
    Publication type:
    Article
    5
    6

    Clinical and structural remission rates increased annually and radiographic progression was continuously inhibited during a 3-year administration of tocilizumab in patients with rheumatoid arthritis: A multi-center, prospective cohort study by the Michinoku Tocilizumab Study Group

    Published in:
    Modern Rheumatology, 2016, v. 26, n. 6, p. 828, doi. 10.3109/14397595.2016.1160991
    By:
    • Yasuhiko Hirabayashi;
    • Yasuhiko Munakata;
    • Masayuki Miyata;
    • Yukitomo Urata;
    • Koichi Saito;
    • Hiroshi Okuno;
    • Masaaki Yoshida;
    • Takao Kodera;
    • Ryu Watanabe;
    • Seiya Miyamoto;
    • Tomonori Ishii;
    • Shigeshi Nakazawa;
    • Hiromitsu Takemori;
    • Takanobu Ando;
    • Takashi Kanno;
    • Masataka Komagamine;
    • Ichiro Kato;
    • Yuichi Takahashi;
    • Atsushi Komatsuda;
    • Kojiro Endo
    Publication type:
    Article
    7

    Discontinuation of etanercept after achievement of sustained remission in patients with rheumatoid arthritis who initially had moderate disease activity--results from the ENCOURAGE study, a prospective, international, multicenter randomized study.

    Published in:
    Modern Rheumatology, 2016, v. 26, n. 5, p. 651, doi. 10.3109/14397595.2015.1123349
    By:
    • Hisashi Yamanaka;
    • Shouhei Nagaoka;
    • Soo-Kon Lee;
    • Sang-Cheol Bae;
    • Tsuyoshi Kasama;
    • Hitomi Kobayashi;
    • Yuichi Nishioka;
    • Yukitaka Ueki;
    • Yohei Seto;
    • Makoto Nishinarita;
    • Naoto Tamura;
    • Noriko Kimura;
    • Kazuyoshi Saito;
    • Tetsuya Tomita;
    • Yasushi Nawata;
    • Sadahiro Suzuki;
    • Yoshiaki Ishigatsubo;
    • Yasuhiko Munakata;
    • Yuichi Makino;
    • Eisuke Inoue
    Publication type:
    Article